Watson Pharmaceuticals Inc has initiated shipments of pyridostigmine bromide tablets, the generic version of Mestinon. Mestinon is used in the treatment of myasthenia gravis, a disorder of neuromuscular transmission, marked by fluctuating weakness and fatigue of certain voluntary muscles.
Watson Pharmaceuticals is a leading specialty pharmaceutical company that develops, manufactures, markets and distributes branded and generic pharmaceutical products. Watson pursues a growth strategy combining internal product development, strategic alliances and collaborations and synergistic.